Fairfield Financial Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Fairfield Financial Advisors's LLY Position: Q1 2026 in Review
Fairfield Financial Advisors increased its Eli Lilly (LLY) stake by 0.05% in Q1 2026, buying an estimated $6.08K and bringing the position to 12,684 shares worth $11.7M. The position accounts for 4.02% of the portfolio, ranked #8.
Fairfield Financial Advisors first reported a position in LLY in Q1 2022 and has held it in 16 quarters since. The position peaked at $13.6M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Fairfield Financial Advisors held 12,684 shares of Eli Lilly worth $11.7M as of Q1 2026.
- Fairfield Financial Advisors bought 6 Eli Lilly shares in Q1 2026, an estimated $6.08K.
- Eli Lilly made up 4.02% of Fairfield Financial Advisors's portfolio in Q1 2026, its #8 holding.
- Fairfield Financial Advisors first reported a position in Eli Lilly in Q1 2022 and has held it in 16 quarters since.
- Fairfield Financial Advisors's Eli Lilly position peaked at $13.6M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Fairfield Financial Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.